The Motley Foolยท2025-09-20 17:25Core Viewpoint - Despite the strong performance of the S&P 500 index, Coca-Cola and Eli Lilly have underperformed, presenting attractive buying opportunities for long-term dividend-seeking investors [1][2]. Group 1: Coca-Cola - Coca-Cola operates in over 200 countries and has seen a 5% revenue growth in the second quarter, excluding foreign currency fluctuations and acquisitions/divestitures [4]. - The revenue increase was driven by higher prices and a changing product mix, contributing 6 percentage points, while lower volume subtracted 1 percentage point [5]. - Coca-Cola has a 3.1% dividend yield, significantly higher than the S&P 500's 1.2%, and a payout ratio of 71%, indicating strong dividend sustainability [7][6]. Group 2: Eli Lilly - Eli Lilly generates significant revenue from three key drugs, which account for 65% of its $15.6 billion second-quarter revenue, with growth rates ranging from 12% to 172% [8]. - The company reported a 38% revenue growth in the second quarter and a 61% increase in adjusted earnings per share to $6.31, with management raising its 2025 revenue guidance to over 35% growth [9]. - Eli Lilly has a 0.8% dividend yield and a 37% payout ratio, with consistent annual dividend increases since 2015, indicating strong earnings coverage for dividends [10].